| Name | Title | Type |
|---|---|---|
| Mahmoud Bah | Chief Operating Officer | Auditee |
| Mark Moyer | CHIEF FINANCIAL OFFICER (INTTERIM) | Auditee |
| Matt Cromwell | Partner- Nonprofit Services | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 309472 | 2023 | 2024-06-21 | Bdo USA PC | $72.71M |
| 27679 | 2022 | 2023-03-05 | Bdo USA LLP | $45.80M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 309472 | 2023 | 2024-06-21 | 977828 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 977827 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 977826 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 977825 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 977824 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 977823 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 977822 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 977821 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 977820 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 977819 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 977818 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 977817 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 977816 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 977815 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 977814 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 401386 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 401385 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 401384 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 401383 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 401382 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 401381 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 401380 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 401379 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 401378 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 401377 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 401376 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 401375 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 401374 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 401373 | 2023-002 | Significant Deficiency | - | H |
| 309472 | 2023 | 2024-06-21 | 401372 | 2023-002 | Significant Deficiency | - | H |